Showing posts with label CB1. Show all posts
Showing posts with label CB1. Show all posts

Brain Abnormalities in Adults and Early Use of Cannabis

Tuesday, 15 January 2019

“As though we need any more reasons to be concerned about the heavy use of cannabis in adolescence, thinning of the brain comes along. Negative effects of chronic adolescent CB use on the hippocampal structure are maintained well into late life. Because hippocampal-cortical loss underlies and exacerbates-related cognitive decline, the findings have profound implications for aging adults with a history of early life usage. A critical brain region the hippocampus (HC), where there is a striking intersection between high concentrations of cannabinoid 1 (CB1) receptors and age-related pathology. They Also Underscores The Persistent Nature of adolescent-induced brain changes due to CB use, and the rising need to understand how these changes interact with brain aging.”
- Dr. David Hepburn

Abstract:

Legalization of cannabis (CB) for both medicinal and, in some states, recreational use, has given rise to increasing usage rates across the country.

Of particular concern are indications that frequent CB use may be selectively harmful to the developing adolescent brain compared with adult-onset usage. However, the long-term effects of heavy, adolescent CB use on brain structure and cognitive performance in late-life remain unknown.

A critical brain region is a hippocampus (HC), where there is a striking intersection between high concentrations of cannabinoid 1 (CB1) receptors and age-related pathology.

Read the full article here:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290479/

Visit

Dr. Dave Hepburn website: https://doctordavidhepburn.com

Muscular Dystrophy and Cannabinoid Receptors

Thursday, 27 December 2018

“As the dysfunction of the endocannabinoid system becomes implicated in more diseases including migraine, irritable bowel, fibromyalgia, epilepsy, and even menstrual cramps now add muscular dystrophy as a potential area of interest for endocannabinoids. Jerry Lewis should be smiling.”
-          Dr. David Hepburn

The endocannabinoid system refers to a widespread signaling system and its alterations implicated in a growing number of human diseases. However, the potential role of endocannabinoids in skeletal muscle is ordered the main sun is known.

In murine and human models, CB1 transcripts how the highest degree of expression at disease onset, and then decline over time. Similar changes are observed for PAX7, a key regulator of muscle stem cells. Bioinformatics and biochemical analysis revealed that PAX7 binds and upregulates the CB1 gene in dystrophic more than in healthy muscles.

Rimonabant, an antagonist of CB1, promotes human satellite cell differentiation in vitro, increases the number of regenerated myofibers, and prevents locomotor impairment in dystrophic mice. In conclusion, our study uncovers a PAX7–CB1 cross-talk potentially exacerbating DMD and highlights the role of CB1 receptors as target for potential therapies.

Read full article here:


Dr. David Hepburn website: https://doctordavidhepburn.com
Related Posts Plugin for WordPress, Blogger...